| Tuesday, June 24, 2025 Abstract Session 27 – CRS – biologics 3 ROOM 10 (G7) | Level +1 09:10h – 10:25h ABSTRACTS |
| Chair 1: Stefania Gallo |
| Chair 2: Gábor Forgács |
| 4254 – Correlation between total IgE levels and blood eosinophils count with disease control and severity in chronic rhinosinusitis with nasal polyps |
| D’Auria Leandro Maria |
| 4255 – Correlation of baseline eosinophil cell counts and baseline serum total IgE level with olfactory improvement and nasal polyp scores in CRSwNP patients during dupilumab treatment. |
| Forgács Gábor |
| 4303 – Multi-Centric Real-World Effectiveness of Mepolizumab in severe Chronic Rhinosinusitis with Nasal Polyps in Germany |
| Bärhold Friederike |
| 4320 – Socioeconomic and Demographic Influences on Biologic Treatment Outcomes in patients with Chronic Rhinosinusitis |
| Biadsee Ameen |
| 4226 – Early Comparative Effectiveness of Dupilumab and Mepolizumab in Patients with Uncontrolled Primary Diffuse Type 2 Chronic Rhinosinusitis |
| Saccardo Tommaso |
| 4236 – Correlation between VAS-smell and Sniffin’ Sticks in chronic rhinosinusitis with nasal polyps treated with biological treatment |
| Geraldes Cláudia |
| 4340 – Effectiveness of Mepolizumab 300 mg in the treatment of patients with severe uncontrolled CRSwNP associated to EGPA: Preliminary Analysis at 1 year of Sinonasal Outcomes |
| Spanu Camilla |
